Mandate

Atria submits a compulsory acquisition offer for all shares in AB Sardus

March 09, 2007

Further to acquiring shares representing 57.1 percent of the share capital and voting rights of AB Sardus after full dilution with regard to issued warrants, Atria has submitted a compulsory acquisition offer for the remaining shares in AB Sardus.

Vinge was adviser to the board of directors of AB Sardus. Johan Winnerblad and Rikard Stenberg represented Vinge.

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026